What are the major opportunities in the Gastric Ulcers market? What are the strategies for the Gastric Ulcers market?

For detailed insights on the major opportunities and strategies in the Gastric Ulcers market, Read More

How does the Gastric Ulcers market relate to the overall economy and other similar markets?

For detailed insights on Gastric Ulcers's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Gastric Ulcers market growth? SWOT analysis of the Gastric Ulcers market.

For detailed insights on the key dynamics influencing the Gastric Ulcers market growth and SWOT analysis of the Gastric Ulcers industry, Read More

Gastric Ulcers Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Gastric Ulcers Market Report 2026

Name: Gastric Ulcers Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes ), By Diagnosis (Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gastric Ulcers Market Overview

• Gastric Ulcers market size has reached to $4.53 billion in 2025

• Expected to grow to $5.78 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%

• Growth Driver: Increasing Geriatric Population Fuels Gastric Ulcers Market Growth

• Market Trend: Advancements In Drug Delivery Systems For Enhanced Efficacy And Safety

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastric Ulcers Market?

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach's inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.

The main types of drug classes in gastric ulcers are proton pump inhibitors (PPI), h2 antagonists, antacids, antibiotics, cytoprotective agents, and others. Proton pump inhibitors (PPI) refer to a class of medications that reduce stomach acid production by inhibiting the proton pump enzyme in gastric cells. Medications that reduce stomach acid production. These ulcers can be diagnosed by stool tests, endoscopies, imaging tests, computed tomography (CT) scans, x-rays, blood tests, and others, and include various routes of administration such as oral, parenteral, and others. Several distribution channels include mainly hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used by various end-users such as hospitals, specialty clinics, homecare, and others.

Gastric Ulcers Market Global Report 2026 Market Report bar graph

What Is The Gastric Ulcers Market Size and Share 2026?

The gastric ulcers market size has grown strongly in recent years. It will grow from $4.53 billion in 2025 to $4.78 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to prevalence of h pylori infection, widespread use of antacids, availability of antibiotics, hospital-based GI treatments, adoption of endoscopic diagnosis.

What Is The Gastric Ulcers Market Growth Forecast?

The gastric ulcers market size is expected to see steady growth in the next few years. It will grow to $5.78 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to development of advanced acid-suppression drugs, demand for long-term ulcer management, growth in outpatient care, improved diagnostic technologies, increased lifestyle-related disorders. Major trends in the forecast period include increased use of proton pump inhibitors, rising focus on helicobacter pylori eradication, growth in combination drug therapies, expansion of non-invasive diagnostic methods, increased awareness of gastrointestinal disorders.

Book your 30 minutes free consultation with our research experts

Global Gastric Ulcers Market Segmentation

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

What Is The Driver Of The Gastric Ulcers Market?

The increasing geriatric population is expected to propel the growth of the gastric ulcers market going forward. The geriatric population refers to individuals typically aged 65 years and older, characterized by specific health considerations related to aging. The increase in the geriatric population is due to advancements in healthcare, leading to longer life expectancy and declining birth rates in many regions globally. Gastric ulcers are common in the geriatric population due to increased use of NSAIDs and decreased mucosal protection, often leading to higher risks of complications. For instance, in January 2024, according to the Population Reference Bureau (PRB), a US-based private non-profit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, this age group's proportion of the total population is anticipated to rise from 17% to 23%. This shift indicates a significant aging trend in the U.S. population. The projections highlight the increasing importance of addressing the needs of older adults in various sectors. Therefore, the increasing geriatric population is driving the growth of the gastric ulcers industry.

Key Players In The Global Gastric Ulcers Market

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Global Gastric Ulcers Market Trends and Insights

Major companies operating in the gastric ulcer market are focusing on developing innovative products, such as new formulations of drugs, to enhance treatment efficacy and reduce side effects. New formulation drugs refer to medications that are developed with innovative combinations of active ingredients, delivery systems, or dosage forms to improve their effectiveness, safety, and patient compliance. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules to provide enhanced relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively treating gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and gastric ulcers. This formulation not only reduces gastric acid secretion but also enhances gastric motility, providing comprehensive relief from symptoms like heartburn and indigestion.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastric Ulcers Market?

In July 2024, Dr. Reddy’s Laboratories, an India-based pharmaceutical company specializing in branded and generic medicines, partnered with Takeda Pharmaceutical Company for Vonoprazan. With this deal, Dr. Reddy’s aims to commercialize Takeda’s next-generation potassium-competitive acid blocker in India, thereby strengthening its gastrointestinal portfolio with a therapy indicated for acid peptic disorders, including gastric ulcer, duodenal ulcer, and Helicobacter pylori-associated disease. Vonoprazan, developed by Takeda, is an orally active acid suppressant used for treating acid-related gastrointestinal conditions.

Regional Outlook

North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastric Ulcers Market?

The gastric ulcers market consists of revenues earned by entities through barium swallow, H. pylori testing, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric ulcers market also includes sales of amoxicillin, clarithromycin, metronidazole, omeprazole, and lansoprazole. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastric Ulcers Market Report 2026?

The gastric ulcers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastric ulcers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gastric Ulcers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.78 billion
Revenue Forecast In 2035	$5.78 billion
Growth Rate	CAGR of 5.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Diagnosis, Route Of Administration, Distribution Channel, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastric Ulcers Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastric Ulcers Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastric Ulcers Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastric Ulcers Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increased Use Of Proton Pump Inhibitors

4.2.2 Rising Focus On Helicobacter Pylori Eradication

4.2.3 Growth In Combination Drug Therapies

4.2.4 Expansion Of Non-Invasive Diagnostic Methods

4.2.5 Increased Awareness Of Gastrointestinal Disorders

5. Gastric Ulcers Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Gastroenterology Clinics

5.3 Retail Pharmacies

5.4 Hospital Pharmacies

5.5 Homecare Providers

6. Gastric Ulcers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastric Ulcers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastric Ulcers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastric Ulcers Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastric Ulcers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastric Ulcers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastric Ulcers Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastric Ulcers Market Segmentation

9.1. Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

9.2. Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

9.3. Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Route Of Administrations

9.4. Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

9.5. Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End Users

9.6. Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

9.7. Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ranitidine, Famotidine, Cimetidine, Nizatidine

9.8. Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

9.9. Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

9.10. Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sucralfate, Misoprostol, Bismuth Subsalicylate

9.11. Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

10. Gastric Ulcers Market Regional And Country Analysis

10.1. Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastric Ulcers Market

11.1. Asia-Pacific Gastric Ulcers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastric Ulcers Market

12.1. China Gastric Ulcers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastric Ulcers Market

13.1. India Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastric Ulcers Market

14.1. Japan Gastric Ulcers Market Overview

14.2. Japan Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastric Ulcers Market

15.1. Australia Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastric Ulcers Market

16.1. Indonesia Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastric Ulcers Market

17.1. South Korea Gastric Ulcers Market Overview

17.2. South Korea Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastric Ulcers Market

18.1. Taiwan Gastric Ulcers Market Overview

18.2. Taiwan Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastric Ulcers Market

19.1. South East Asia Gastric Ulcers Market Overview

19.2. South East Asia Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastric Ulcers Market

20.1. Western Europe Gastric Ulcers Market Overview

20.2. Western Europe Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastric Ulcers Market

21.1. UK Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastric Ulcers Market

22.1. Germany Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastric Ulcers Market

23.1. France Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastric Ulcers Market

24.1. Italy Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastric Ulcers Market

25.1. Spain Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastric Ulcers Market

26.1. Eastern Europe Gastric Ulcers Market Overview

26.2. Eastern Europe Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastric Ulcers Market

27.1. Russia Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastric Ulcers Market

28.1. North America Gastric Ulcers Market Overview

28.2. North America Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastric Ulcers Market

29.1. USA Gastric Ulcers Market Overview

29.2. USA Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastric Ulcers Market

30.1. Canada Gastric Ulcers Market Overview

30.2. Canada Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastric Ulcers Market

31.1. South America Gastric Ulcers Market Overview

31.2. South America Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastric Ulcers Market

32.1. Brazil Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastric Ulcers Market

33.1. Middle East Gastric Ulcers Market Overview

33.2. Middle East Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastric Ulcers Market

34.1. Africa Gastric Ulcers Market Overview

34.2. Africa Gastric Ulcers Market, Segmentation By Drug Class, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastric Ulcers Market Regulatory and Investment Landscape

36. Gastric Ulcers Market Competitive Landscape And Company Profiles

36.1. Gastric Ulcers Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastric Ulcers Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastric Ulcers Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Gastric Ulcers Market Other Major And Innovative Companies

Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd

38. Global Gastric Ulcers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastric Ulcers Market

40. Gastric Ulcers Market High Potential Countries, Segments and Strategies

40.1 Gastric Ulcers Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastric Ulcers Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastric Ulcers Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Gastric Ulcers Market, Overview Of Key Products - Product Examples

Table 2: Global Gastric Ulcers Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Gastric Ulcers Market, Supply Chain Analysis

Table 4: Global Gastric Ulcers Market, Major Raw Material Providers

Table 5: Global Gastric Ulcers Market, Major Resource Providers

Table 6: Global Gastric Ulcers Market, Major Manufacturers (Suppliers)

Table 7: Global Gastric Ulcers Market, Major Distributors And Channel Partners

Table 8: Global Gastric Ulcers Market, Key Technologies & Future Trends

Table 9: Global Gastric Ulcers Market, Major Trends

Table 10: Global Gastric Ulcers Market, Major End Users

Table 11: Global Gastric Ulcers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Gastric Ulcers Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Gastric Ulcers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Gastric Ulcers Market - TAM, US$ Billion, 2025

Table 15: Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Global Gastric Ulcers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 101: Global Gastric Ulcers Market - Company Scoring Matrix

Table 102: Pfizer Inc. Financial Performance

Table 103: Merck & Co Inc. Financial Performance

Table 104: AbbVie Inc. Financial Performance

Table 105: Sanofi S.A. Financial Performance

Table 106: AstraZeneca plc Financial Performance

Table 107: Global Gastric Ulcers Market, Competitive Benchmarking (In USD Billions)

Table 108: Global Gastric Ulcers Market, Competitive Dashboard

Table 109: Global Gastric Ulcers Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 110: Global, Gastric Ulcers Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 111: Global, Gastric Ulcers Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 112: Global, Gastric Ulcers Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Gastric Ulcers Market, Overview Of Key Products - Product Examples

Figure 2: Global Gastric Ulcers Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Gastric Ulcers Market, Supply Chain Analysis

Figure 4: Global Gastric Ulcers Market, Major Raw Material Providers

Figure 5: Global Gastric Ulcers Market, Major Resource Providers

Figure 6: Global Gastric Ulcers Market, Major Manufacturers (Suppliers)

Figure 7: Global Gastric Ulcers Market, Major Distributors And Channel Partners

Figure 8: Global Gastric Ulcers Market, Key Technologies & Future Trends

Figure 9: Global Gastric Ulcers Market, Major Trends

Figure 10: Global Gastric Ulcers Market, Major End Users

Figure 11: Global Gastric Ulcers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Gastric Ulcers Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Gastric Ulcers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Gastric Ulcers Market - TAM, US$ Billion, 2025

Figure 15: Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Global Gastric Ulcers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 101: Global Gastric Ulcers Market - Company Scoring Matrix

Figure 102: Pfizer Inc. Financial Performance

Figure 103: Merck & Co Inc. Financial Performance

Figure 104: AbbVie Inc. Financial Performance

Figure 105: Sanofi S.A. Financial Performance

Figure 106: AstraZeneca plc Financial Performance

Figure 107: Global Gastric Ulcers Market, Competitive Benchmarking (In USD Billions)

Figure 108: Global Gastric Ulcers Market, Competitive Dashboard

Figure 109: Global Gastric Ulcers Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 110: Global, Gastric Ulcers Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 111: Global, Gastric Ulcers Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 112: Global, Gastric Ulcers Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

AL Amyloidosis Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Anemia In Elderly Market Trends: Regional Breakdowns and Strategic Insights

Artificial Intelligence (AI) In Aging And Elderly Care Outlook 2034: Key Drivers, Trends, and Market Frontiers

Artificial Intelligence-Powered Solutions For Elderly CareMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Peptic Ulcer Market Report 2026 - Global Outlook – By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), By Drug Type (Proton Pump Inhibitors (PPI), H2 Antagonists, Ant...

Pressure Ulcers Treatment Market Report 2026 - Global Outlook – By Type (Wound Care Dressings, Wound Care Devices, Active Therapies, Other Types), By Wound Type (Stage 1, Stage 2, Stage 3, Stage 4), By End-User (Hospital...

Duodenal Ulcer Treatment Market Report 2026 - Global Outlook – By Type (Antibiotics, Proton Pump Inhibitors, Antacids, Potassium-Competitive Acid Blockers, H2-Antagonist, Ulcer Protective Drugs, Surgery), By Application ...

Gastric Cancer Diagnostic Procedure Market Report 2026 - Global Outlook – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multipl...

Ulcerative Colitis Market Report 2026 - Global Outlook – By Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types), By Disease Type (Ulcerative Proctitis, Pro...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) - Market...

Gastric Volvulus Treatment Market Report 2026 - Global Outlook – By Type (Organo-Axial Volvulus, Mesentero-Axial Volvulus), By Treatment Type (Medication, Surgery), By Route Of Administration (Oral, Parenteral), By Distr...

Frequently Asked Questions

How big is the Gastric Ulcers Market?

The Gastric Ulcers market was valued at $4.53 billion in 2025, increased to $4.78 billion in 2026, and is projected to reach $5.78 billion by 2030. request a sample here

What is the Gastric Ulcers market growth?

The global Gastric Ulcers market is expected to grow at a CAGR of 4.9% from 2026 to 2035 to reach $5.78 billion by 2035. request a sample here

Who are the key players in Gastric Ulcers market?

Some Key Players in the Gastric Ulcers market Include, Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC . request a sample here

What is the anticipated growth trend for the Gastric Ulcers market?

Major trend in this market includes: Advancements In Drug Delivery Systems For Enhanced Efficacy And Safety . For further insights on this market. request a sample here

Which region has the most growth potential in the Gastric Ulcers market?

North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Gastric Ulcers Market Report 2026 market?

Major companies operating in the Gastric Ulcers Market Report 2026 market are Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC request a sample here.

Which region has the most growth potential in the Gastric Ulcers Market Report 2026 market?